Fisher Center Discovery Award (FCDA)

The Fisher Center Discovery Award (FCDA) aims to support research projects focused on improved understanding of human illness, patient outcomes, or public health in North America. The award is designed especially for trainees, new investigators, and junior faculty looking to acquire pilot data and grant-writing experience. The goals of the FCDA are:

  • To promote research by awarding funds to support projects focused on clinical or translational research in one or more of THREE topic areas:
    • 1. Environmental infectious diseases, which include human disease-causing agents found in ecological environments such as air, soil, and water; vector-borne or zoonotic diseases; and those found in built environments like home, hospital, and community
    • 2. Antimicrobial resistance
    • 3. Post-infectious conditions such as long COVID or persistent symptoms after Lyme disease treatment
  • To provide expertise, resources, and mentorship opportunities for pilot or clinical studies with a relative lack of traditional funding mechanisms
  • To promote novel, cross-disciplinary, collaborative clinical research among schools at Johns Hopkins University and with non-Johns Hopkins University research partners
  • To facilitate the careers of early career researchers (faculty or trainees) by providing funds for projects joined with a more senior investigator capable of providing hands-on training and mentoring in the science of clinical investigation

Basic laboratory research proposals will not be reviewed. Laboratory-based research will only be considered if it is directly related to clinical or translational research. International projects may be considered only if relevant to North American healthcare, and if the work cannot be readily performed domestically. Any full-time faculty members or trainees from Johns Hopkins University, including the Schools of Medicine, Public Health, Nursing, Engineering, Business, Arts and Sciences, and Applied Physics Lab, may apply and act as principal investigator.

Application Timeline

Letter of Intent Deadline: November 29, 2024
Application Deadline: December 20, 2024
Award Notice: On or before March 7, 2025
Release of Funds: April 7 - April 30, 2025

This timeline may be subject to change. Please email fishercenter@jhmi.edu with any questions.

 Fisher Center Discovery Award (FCDA)



Project Topics Must involve one or more of three areas:
  • Environmental Infectious Diseases
  • Antimicrobial Resistance (AMR)
  • Post-infectious Conditions
Eligible Applicants Full-time JH faculty or trainees (with a JH faculty mentor) from any school or department/division 
Eligible Principal Investigators Full-time JH faculty from any school or department/division 
Budget Up to $60,000.00
Personnel Support No salary support beyond the level of Assistant Professor
Number of Available Grants Up to four (4)
Grant Period 12 months after start, with an option for one 12-month NCE
Project Start Date April 7 – April 30, 2025
Application Deadline Friday, December 20, 2024

Application Documents
(Must use provided templates)

2025 FCDA Document Library may be found at the links below or by submitting a request to Diane Lanham (dlanham1@jhmi.edu):
Other Application Documents
(To be created by the applicant)
  • Research Protocol (required)
  • Letters of Support (may be required)
  • Biosketches, CVs, or resumes for all study team members receiving salary support
  • Budget Justification (if personnel costs exceed 50% of total budget)
  • Budget Justification (if supplies and equipment costs exceed 50% of total budget)

To apply for the Fisher Center Discovery Award (12 months, $60,000):

  1. Submit all documents via email to fishercenter@jhmi.edu before 11:59pm on December 20, 2024
  2. Save all documents as individual files; do not combine documents
  3. The complete FCDA application package is composed of the following:
  • FCDA Application Form 2025
  • Protocol: Abstract, background, objectives, methods, timeline, proposal benefits, endnotes
  • Biosketch, Curriculum Vitae, or resume (saved as individual files) for:
    • Principal investigator
    • Co-investigator(s)
    • Staff receiving salary support
  • Letter of support from the faculty preceptor for applicants who are not JHU faculty
  • Optional, but encouraged: Letters of support from collaborators and research partners (saved as individual files)
  • FCDA Budget Template 2025
  • Written justification of salary requests exceeding 50% of the monetary award, if necessary
  • Written justification of laboratory supplies, equipment, and service requests exceeding 50% of the monetary award, if necessary

FCDA Past Awardees

Principal Investigators were Johns Hopkins University faculty at the time of award. Co-investigators are not listed.

Year Principal Investigator Project Title
2025 Shahbaz Khan, PhD  Repurposing Acyltransferase Inhibitors for Toxoplasma Drug Development
2025 Nate Permpalung, MD, MPH  Impact of neighborhood-level environmental and social determinants of health on invasive fungal infection risk
2025 Gyanu Lamichhane, PhD  A search for phages and synergistic drug combinations to treat environmentally acquired non-tuberculous mycobacterial diseases
2025 David Dowdy, MD, PhD  Predicting West Nile virus risk in Maryland using machine learning and local data
2025 Andrew Karaba, MD, PhD  Assessing Immunity against Highly Pathogenic Avian Influenza in Immunocompromised Persons
2025 Thomas M. Hart, PhD
 Exploring Borrelia burgdorferi host sensing as a Lyme disease vaccine target
2024 Annie Antar, MD, PhD Modeling SARS-CoV-2 Reservoirs as a Platform to Advance Long COVID Therapeutics
2024 Johan Melendez, PhD
Characterizing the evolution of antimicrobial resistance in Neisseria gonorrhoeae mediated by exchange of genetic material
2024 James Gordy, PhD
Analysis of Borrelia burgdorferi derived extracellular vesicles from serum to identify persistent infection and the role of the Bb stringent response
2024 Elizabeth Thompson, PhD
Targeting immunometabolic regulation to mediate recovery in post-acute sequalae of SARS-CoV-2 infection (PASC)
2023 Maxim Rosario, D.Phil., PhD, MSc, MB BCh BAO
Optimizing the Selection of Donors for Adoptive Cell Therapy for Environment Fungal Infections
2023 Kimia Ghobadi, PhD
James C. Fackler, MD

Creation of a comprehensive microbiogram, visualizing the microbe prevalences in real-time at the neighborhood level
2022 Monica Mugnier, PhD
Defining the immune mechanisms mediating congenital transmission of Trypanosoma cruzi
2022 Carsten Prasse, PhD
Antiviral drugs as previously unrecognized contributors to antibiotic resistance
2022 Santosh Dhakal, DVM, PhD
Antibody dynamics as the biomarkers of COVID-19 outcomes among hospitalized patients
2022
Mark Ranek, PhD
Targeting the confluence of obesity and COVID-19
2022 Sam Das, PhD Fully automated at-home COVID-19 test
2021 Netz Arroyo, PhD
Point-of-need platform for population-scale monitoring of SARS-CoV-2 neutralizing antibodies
2021 Challice Bonifant, MD PhD
H84T-BanLec CAR-NK Cells as Treatment for SARS-CoV-2 Infection
2021 Karen Carroll, MD
Next Generation Sequencing for Pathogen Identification in Lower Respiratory Infections
2021 Meghan Frost Davis, DVM, MPH PhD
Immunologic markers associated with environmental exposure to enterotoxin-producing Staphylococcus aureus
2021 Maged Mohamed Harraz, MBBCh, MSc, PhD
Autophagic degradation of ACE2 as a Therapeutic Target in Covid-19
2021 Nitipong “Nate” Permapalung, MD, MPH
Optimizing Diagnostics for Environmentally Acquired Fungal Pneumonia Complicating COVID-19
2021 Matthew Robinson, MD
A comprehensive suite of web tools to predict COVID-19 trajectory
2021 Maxim Rosario, D.Phil., MB BCH BAO, MSc PhD
Adoptive NK cell Therapy for Acquired Fungal Infection
2020 Keira Cohen, MD
Early bactericidal activity of standard drugs used to treat Mycobacterium avium complex: a pilot study
2020 Gyanu Lamichhane, PhD
Developing antibiotic regimen to treat M. abscessus disease based on whole genome mining
2020 Michael Melia, MD
Beta-d-glucan and galactomannan curriculum
2020
Heba Mostafa, MD, PhD
Genomic Surveillance of Enteroviruses' Polymorphic Events that Correlate with Disease Severity and Neuro-virulence
2020 David Sullivan, MD
Murine Babesia Combination Chemotherapy
2020 Sean Zhang, MD, PhD
POC.auris: A 15-minute point-of-care detection of multi-drug resistant Candida auris

Funding Our Future

While many of the investigators in the Division of Infectious Diseases receive grant funding for their research, there are other critical activities that rely primarily on private donations. You can make your gift online directly by using our secure giving form.